Imatinib Completed Phase 2 Trials for Cancer, Breast Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00323063Gemcitabine +/- Imatinib Mesylate, Patients w/Previously Treated Metastatic Breast Cancer
NCT00193180Docetaxel Plus Imatinib Mesylate in Metastatic Breast Cancer
NCT00087152S0338, Imatinib Mesylate and Capecitabine in Treating Women With Progressive Stage IV Breast Cancer